Biotech

All Articles

FDA locations Kezar lupus test in grip following 4 individual fatalities

.The FDA has actually positioned Kezar Lifestyle Sciences' lupus test on grip after the biotech hail...

Phase 3 Intellectual Rock trial hits SMA goal, sending out stock up 200%

.A period 3 test of Academic Rock's vertebral muscular atrophy (SMA) candidate has attacked its own ...

CAMP 4 is most current to eye IPO, while Upstream spells out $182M plan

.RNA biotech CAMP4 Rehabs has defined plans for a $67 thousand IPO, with inflammation-focused Upstre...

Galecto acquires leukemia medicine, falls bone cancer cells asset in pivot

.A year after the breakdown of an idiopathic lung fibrosis prospect sent Galecto on a seek redemptio...

Judo throws down $100M to knock senseless kidney health condition

.Taking the floor covering is Judo Bio, an ambitious biotech equipped along with $100 thousand to de...

AstraZeneca pays out CSPC $100M for preclinical heart problem medicine

.AstraZeneca has paid CSPC Drug Group $one hundred million for a preclinical heart disease medicatio...

Zephyrm seeks Hong Kong IPO to cash period 3 tissue therapy tests

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, submitting (PDF) for an ...

Frazier Lifestyle Sciences gathers $630M for small, mid-cap biotechs

.Frazier Lifespan Sciences has sourced an even further $630 thousand for its fund paid attention to ...

GigaGen gathers approximately $135M BARDA bucks to hammer botox

.Antibody aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its own speci...

GPCR firm Septerna declare IPO on stamina of preclinical information

.Septerna is about to find out exactly how a biotech without "any sort of meaningful professional re...